[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335420-105":59,"doc-detail-335420-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","a-novel-methylation-detection-panel-for-hpv-associated-high-grade-squamous-intraepithelial-lesion-and-cervical-cancer-screening","A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening","","Cervical cancer (CC), the leading cause of death among women with advanced-stage diagnoses, requires accurate early detection tools. This study evaluated whether a multi-locus DNA methylation assay can predict CC using cervical exfoliated cell samples from 492 HPV-positive women with cervical lesions. After bisulfite conversion, methylation of FAM19A4, EPB41L3, and PAX1 was measured and compared across lesion severities via ROC analysis. Individual markers showed sensitivities of 84.6%, 86.3%, and 88.0% for HSIL and CC, while combined tri-gene logistic regression achieved 88.0% sensitivity, 97.7% specificity, and AUC 0.957, supporting triage for early screening.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-novel-methylation-detection-panel-for-hpv-associated-high-grade-squamous-intraepithelial-lesion-and-cervical-cancer-screening/335420/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-novel-methylation-detection-panel-for-hpv-associated-high-grade-squamous-intraepithelial-lesion-and-cervical-cancer-screening/335420.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the goal of the multi-locus methylation study for cervical cancer screening?","Question",{"text":113,"@type":114},"To evaluate the predictive value of a multi-locus DNA methylation assay for early detection of cervical cancer.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which genes were included in the methylation-detection panel?",{"text":118,"@type":114},"FAM19A4, EPB41L3, and PAX1 were measured after bisulfite conversion.",{"name":120,"@type":111,"acceptedAnswer":121},"How did tri-gene methylation perform compared with single markers for diagnosing HSIL and cervical cancer?",{"text":122,"@type":114},"Single markers achieved sensitivities of 84.6%, 86.3%, and 88.0%, while the combined logistic regression model reached 88.0% sensitivity, 97.7% specificity, and AUC of 0.957.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},335420,1790131418,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nA novel methylation-detection panel for HPV associated highgrade squamous intraepithelial lesion and cervical cancer screening  \nXiaobo Cheng1,4, Ranran Chai1,4, Teng Zhang2,3,4, Yanjie Chen1, Fangqin Fan1, Yingfei Ye1, Guanqin Jin1, Tingting Li1, Hui Wang1, Jingwen Ding1, Min Zheng1, Yanhua Han1, Qinzhu Tang1, Zhiqing Song1, YiqunJi2, Wengweng Song2, Weifeng Luo2,3􀀍 & Yu Kang1􀀍  \nCervical cancer (CC) was considered to be the most common gynaecological cancer, with an estimated 342,000 deaths worldwide each year, as the majority of patients were diagnosed at an advanced stage of the disease. The purpose of this study was to evaluate the predictive value of multi-locus methylation assay for the early detection of CC. The cervical exfoliated cell samples from 492 HPVpositive females with cervical lesions were collected and subjected to methylation detection of gene FAM19A4, EPB41L3 and PAX1 after bisulfite conversion. The levels of gene methylation in patients with different severity of cervical lesions were evaluated and compared. The receiver-operating characteristic (ROC) curve was established and efficacy indexes such as sensitivity, specificity and area under the curve (AUC) were calculated to assess the diagnostic value of DNA methylation detection at multiple gene loci for CC. The methylation levels of FAM19A4, EPB41L3 and PAX1 were significantly increased with the grade of cervical squamous intraepithelial lesions. The sensitivities of FAM19A4, EPB41L3 and PAX1 alone for high-grade squamous intraepithelial lesion (HSIL) and CC diagnosis were 84.6%, 86.3% and 88.0%, respectively; when three markers were combined by a logistic regression model, the sensitivity was 88.0%, with a high specificity of 97.7% andAUC of 0.957 (95% CI 0.937–  \n0.977). Methylation status of FAM19A4, EPB41L3 and PAX1 were highly specific and effective for monitoring the progression of cervical lesions and the tri-gene methylation assay could be used as atriage tool for CC early screening.  \nKeywords DNA methylation detection, Early screening, Cervical squamous intraepithelial lesion, Cervical cancer  \nAbbreviations  \nLSIL Low-grade squamous intraepithelial lesion HSIL High-grade squamous intraepithelial lesion CC Cervical cancer  \nhrHPV High-risk human papillomavirus HPV human papillomavirus  \nROC The receiver-operating characteristic curve  \nAUC Area under the curve  \nCI Confidence interval  \nMSP Methylation-specific PCRANOVA One-way analysis of variance  \nVAR Value at risk  \nSCC Squamous cell carcinoma  \nAC Adenocarcinoma  \n1Clinical Trials Unit, Obstetrics and Gynecology Hospital of Fudan University, 200090 Shanghai, People’s Republic of China. 2Shanghai Ruisai Biotechnology Co., Ltd, No. 3399 Kangxin Highway, Pudong New Area, Shanghai, China. 3Zhejiang Free Trade Area R&S Biomedical Technology Co., Ltd, Zhoushan, Zhejiang, China. 4Xiaobo Cheng, Ranran Chai and Teng Zhang are co-first authors and have contributed equally to this work. 􀀍 email:  \n[weifeng.luo@research-bio.com](weifeng.luo@research-bio.com); [yukang@fudan.edu.cn](yukang@fudan.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nTCT Thinprep cytologic test  \nOver the past few decades, cervical cancer (CC), with the increasing morbidity, has been seriously harming human health and becomes a leading cause of female death worldwide in modern society1. The persistent infection of high-risk human papillomavirus (hrHPV) is an important factor in the development and progression of CC, and almost all patients with CC are HPV-positive2. Currently, cervical liquid-based cytology examination and hrHPV testing have been proposed as the main CC screening methods. However, the sensitivity and specificity of these methods are limited, leading to an increase in colposcopy referrals, thereby increasing the physical and mental burden on women3,4. Therefore, a cost-benefical screening strate","cbCaiqTii279bNlC","https://ap.wps.com/l/cbCaiqTii279bNlC","pdf",1554876,"English","# Materials and methods\n## Study participants and samples","[{\"question\":\"What was the goal of the multi-locus methylation study for cervical cancer screening?\",\"answer\":\"To evaluate the predictive value of a multi-locus DNA methylation assay for early detection of cervical cancer.\"},{\"question\":\"Which genes were included in the methylation-detection panel?\",\"answer\":\"FAM19A4, EPB41L3, and PAX1 were measured after bisulfite conversion.\"},{\"question\":\"How did tri-gene methylation perform compared with single markers for diagnosing HSIL and cervical cancer?\",\"answer\":\"Single markers achieved sensitivities of 84.6%, 86.3%, and 88.0%, while the combined logistic regression model reached 88.0% sensitivity, 97.7% specificity, and AUC of 0.957.\"}]","A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening | PDF",1790010935,23]